Zhang Chaowei, Zink Deborah L, Ushio Misti, Burgess Bruce, Onishi Russell, Masurekar Prakash, Barrett John F, Singh Sheo B
Merck Research Laboratories, Rahway, NJ 07065, USA.
Bioorg Med Chem. 2008 Oct 1;16(19):8818-23. doi: 10.1016/j.bmc.2008.08.079. Epub 2008 Sep 6.
Thiazolyl peptides are a class of thiazole-rich macrocyclic potent antibacterial agents. Recently, we described thiazomycin, a new member of thiazolyl peptides, discovered by a thiazolyl peptide specific chemical screening. This method also allowed for the discovery of a new thiazolyl peptide, thiazomycin A, which carries modification in the oxazolidine ring of the amino sugar moiety. Thiazomycin A is a specific inhibitor of protein synthesis (IC(50) 0.7 microg/mL) and a potent Gram-positive antibacterial agent with minimum inhibitory concentration (MIC) ranging 0.002-0.25 microg/mL. The isolation and structure elucidation and biological activities of thiazomycin A are described.
噻唑基肽是一类富含噻唑的大环强效抗菌剂。最近,我们描述了噻唑霉素,它是噻唑基肽的一个新成员,通过噻唑基肽特异性化学筛选发现。该方法还促成了一种新的噻唑基肽——噻唑霉素A的发现,它在氨基糖部分的恶唑烷环上有修饰。噻唑霉素A是一种蛋白质合成的特异性抑制剂(IC(50)为0.7微克/毫升),也是一种强效革兰氏阳性抗菌剂,最低抑菌浓度(MIC)范围为0.002 - 0.25微克/毫升。本文描述了噻唑霉素A的分离、结构解析及生物活性。